Sai Life Sciences has reported results for the fourth quarter (Q4FY26) and year ended March 31, 2026.
The company has reported 14.00% rise in its net profit at Rs 102.53 crore for the quarter under review as compared to Rs 89.94 crore for the same quarter in the previous year. The total income of the company has increased by 5.77% at Rs 610.09 crore for Q4FY26 as compared to Rs 576.83 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 18.09% rise in its net profit at Rs 104.24 crore for the fourth quarter ended March 31, 2026 as compared to Rs 88.27 crore for the same quarter in the previous year. The total income of the company increased by 4.85% at Rs 617.66 crore for Q4FY26 as compared to Rs 589.11 crore for the corresponding quarter previous year.
For the year ended March 31, 2026, the company has reported 96.86% jump in its net profit at Rs 341.48 crore as compared to Rs 173.46 crore for the previous year. The total income of the company has increased by 31.14% at Rs 2,202.36 crore for year under review as compared to Rs 1,679.38 crore for year ended March 31, 2025.
For the year ended March 31, 2026, on the consolidated basis, the company has reported over two-fold jump in its net profit at Rs 348.91 crore as compared to Rs 170.13 crore for the previous year. The total income of the company increased by 29.47% at Rs 2,241.62 crore for year under review as compared to Rs 1,731.35 crore for year ended March 31, 2025.
